Literature DB >> 9326453

Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro.

D A Puleo1.   

Abstract

Bone morphogenetic proteins (BMPs) induce osteoblastic responses in cultures of pluripotent mesenchymal cells. The effects of chronic treatment of these cells with BMPs and of withdrawal following exposure, however, have not been fully elucidated. Thus, the aim of this study was to obtain information about the duration of exposure to recombinant human BMP-2 (rhBMP-2) required for expression and retention of osteoblastic characteristics with subsequent formation of a mineralized extracellular matrix in mesenchymal cell cultures. C3H1OT1/2 cells and bone marrow stromal cells were cultured with 1 mug/ml rhBMP-2 for either 0, 7, 14, 21, or 28 days, with the remainder of the 4 week total culture period in the absence of rhBMP-2. Growth and expression of osteoblastic characteristics were examined at the end of each week. C3H1OT1/2 cells responded to increasing duration of exposure to rhBMP-2 with increased cell growth. Additionally, the longer the cells were exposed to rhBMP-2, the more fully they expressed and sustained osteoblastic traits, i.e., they exhibited duration of exposure-dependent higher levels of alkaline phosphatase and osteocalcin and larger total amounts of mineral in the matrix. In comparison, exposure of bone marrow stromal cells to rhBMP-2 for at least 14 days restrained cell growth and prevented detachment. With respect to osteoblastic traits, stromal cells exposed to rhBMP-2 also exhibited a dependence on the duration of exposure, however, cultures treated for 14, 21, or 28 days exhibited similar levels of alkaline phosphatase activity and comparable amounts of calcium in the mineralizing matrix.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326453     DOI: 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  In vivo bone formation by human bone marrow cells: effect of osteogenic culture supplements and cell densities.

Authors:  S C Mendes; I Van Den Brink; J D De Bruijn; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

2.  Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.

Authors:  B H Woo; B F Fink; R Page; J A Schrier; Y W Jo; G Jiang; M DeLuca; H C Vasconez; P P DeLuca
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

3.  Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces.

Authors:  Jae Sam Lee; Jae Sung Lee; William L Murphy
Journal:  Acta Biomater       Date:  2009-08-06       Impact factor: 8.947

4.  Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines.

Authors:  N Yanai; M Obinata
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

5.  Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials.

Authors:  Christine J Kowalczewski; Seth Tombyln; David C Wasnick; Michael R Hughes; Mary D Ellenburg; Michael F Callahan; Thomas L Smith; Mark E Van Dyke; Luke R Burnett; Justin M Saul
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

6.  The influence of bone formation on anchoring percutaneous devices with titanium fibre mesh flanges.

Authors:  M M Shalabi; X F Walboomers; J A Jansen
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

7.  The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation.

Authors:  Byung-Chul Jeong; Yong-Soo Lee; Yun-Yong Park; In-Ho Bae; Don-Kyu Kim; Seung-Hoi Koo; Hong-Ran Choi; Sun-Hun Kim; Renny T Franceschi; Jeong-Tae Koh; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

8.  The orphan nuclear receptor SHP is a positive regulator of osteoblastic bone formation.

Authors:  Byung-Chul Jeong; Yong-Soo Lee; In-Ho Bae; Chul-Ho Lee; Hong-In Shin; Hyun Jung Ha; Renny T Franceschi; Hueng-Sik Choi; Jeong-Tae Koh
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

9.  Effect of low-intensity pulsed ultrasound on scaffold-free ectopic bone formation in skeletal muscle.

Authors:  Munenori Watanuki; Koshi N Kishimoto; Satoshi Kotajima; Sadahiro Iwabuchi; Shoichi Kokubun
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

10.  Surface-mediated delivery of siRNA from fibrin hydrogels for knockdown of the BMP-2 binding antagonist noggin.

Authors:  Christine J Kowalczewski; Justin M Saul
Journal:  Acta Biomater       Date:  2015-07-30       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.